# Ovarian cancer action appoints new Chief Executive

- Link: https://fundraising.co.uk/2008/06/05/ovarian-cancer-action-appoints-new-chief-executive/
- Published: 2008-06-05T12:17:34+01:00
- Author: Howard Lake

![](https://www.fundraising.co.uk/files/images/newswire/Peter_reynolds_1212668234.
jpg)

Ovarian cancer action, the UK’s leading ovarian cancer charity, has appointed Peter
Reynolds as Chief Executive. He joins the charity from Children with Leukaemia, 
where he was Deputy Chief Executive.

Peter brings over twenty years experience of working in the commercial and charity
sectors to Ovarian cancer action. Over the past eight years, he has held senior 
management roles within two organisations with a focus on cancer, Children with 
Leukaemia and Breakthrough Breast Cancer, where he was the Director of Fundraising
and Communications.

He comments on his ambitions for Ovarian cancer action: “Ovarian cancer devastates
the lives of thousands of women and their families every year in this country – 
and survival rates remain shockingly poor. Ovarian cancer action has already made
great strides in the fight against the disease and I am looking forward to building
on those achievements in the future.”

## Advertisement

 [⌊Posthub advert. You create the campaign. We'll handle the postal journey. Get started at post-hub.co.uk.⌉](https://fundraising.co.uk/ads/posthub-20261007-300x250/)

Ovarian cancer action aims to improve women’s chances of survival through better
awareness and world-class research. The charity has made significant progress in
ensuring that research into the disease is prioritised and that more women and GPs
are aware of the symptoms of the disease.

…ENDS…

Editor’s notes:

o Ovarian cancer action is dedicated to improving survival rates for ovarian cancer
through funding research, raising awareness and giving a voice.

o Ovarian cancer is the fourth most common cancer in the UK after breast, lung and
bowel. 7,000 women are diagnosed in the UK every year and 12 die every day. UK survival
rates have NOT improved in 20 years remaining low at 30%, compared with an increase
to 80% for breast cancer. If diagnosed at early stage, women have up to a 95% chance
of survival, but alarmingly many women do not know what symptoms to look out for.

o In 2006, the Ovarian Cancer Action Research Centre was opened, which is the first
research centre of its kind in the UK. The Centre is a collaboration between Hammersmith
Hospital, Imperial College London, The Royal Marsden Hospital and the Institute 
of Cancer Research and it looks at fundamental biology, early detection and new 
and improved treatments.

 * **[Childrens' Hospices UK rebrand](https://fundraising.co.uk/2008/06/09/childrens039-hospices-uk-rebrand/)**(
   9 June 2008)
 * **[NCH challenged over rebranding](https://fundraising.co.uk/2008/06/13/nch-challenged-over-rebranding/)**(
   13 June 2008)
 * **[Turn2us appoints its first head of fundraising](https://fundraising.co.uk/2008/06/27/turn2us-appoints-its-first-head-fundraising/)**(
   27 June 2008)